Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 7, Issue 11, Pages 1411-1429
Publisher
Informa Healthcare
Online
2011-10-17
DOI
10.1517/17425255.2011.627854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rhabdomyolysis Induced by Simvastatin-Fluconazole Combination
- (2016) Ribhi Hazin et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3
- (2010) Miho Nara et al. AMERICAN JOURNAL OF HEMATOLOGY
- Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles
- (2010) Hiroshi Yamazaki et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data
- (2010) I Templeton et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Investigation into UDP-Glucuronosyltransferase (UGT) Enzyme Kinetics of Imidazole- and Triazole-Containing Antifungal Drugs in Human Liver Microsomes and Recombinant UGT Enzymes
- (2010) K. Bourcier et al. DRUG METABOLISM AND DISPOSITION
- Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients
- (2009) T Mori et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers
- (2009) Gopal Krishna et al. CLINICAL THERAPEUTICS
- Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance
- (2009) Bo Wang et al. CURRENT DRUG METABOLISM
- Effects of oral posaconazole on the pharmacokinetics of sirolimus
- (2009) Allen Moton et al. CURRENT MEDICAL RESEARCH AND OPINION
- In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3
- (2009) S. B. Yanni et al. DRUG METABOLISM AND DISPOSITION
- Polymorphism of human cytochrome P450 enzymes and its clinical impact
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- Effects of Oral Posaconazole on the Pharmacokinetics of Atazanavir Alone and With Ritonavir or With Efavirenz in Healthy Adult Volunteers
- (2009) Gopal Krishna et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Clinically relevant drug interactions of current antifungal agents
- (2009) Paul O. Gubbins et al. MYCOSES
- Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A
- (2008) S. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers
- (2008) Bharat Damle et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Flavin-Containing Monooxygenase in Oxidative Metabolism of Voriconazole by Human Liver Microsomes
- (2008) S. B. Yanni et al. DRUG METABOLISM AND DISPOSITION
- The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
- (2008) Guo Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- (2008) Johanna Weiss et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients
- (2008) Dirk R. Kuypers et al. Pharmacogenetics and Genomics
- Cytochrome P450 and Chemical Toxicology
- (2007) F. Peter Guengerich CHEMICAL RESEARCH IN TOXICOLOGY
- Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects
- (2007) Ping Liu et al. JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now